aluates Reports

$ 0.0

Automative

Global Cancer Immunotherapy Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-26I13307

Global Cancer Immunotherapy Market Research Report 2023

BUY CHAPTERS

Global Cancer Immunotherapy Market Research Report 2025

Code: QYRE-Auto-26I13307

Report

July 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Astrazeneca plc

Roche

Bayer

Bristol–Myers Squibb

Eli Lilly

Merck

Novartis

Pfizer Inc

Cancer Immunotherapy Market Size

The global market for Cancer Immunotherapy was valued at US$ 68170 million in the year 2024 and is projected to reach a revised size of US$ 240180 million by 2031, growing at a CAGR of 20.0% during the forecast period.

Cancer Immunotherapy Market

Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body"s natural defenses to fight cancer.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cancer Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Immunotherapy.

The Cancer Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Immunotherapy Market Report

Report Metric	Details
Report Name	Cancer Immunotherapy Market
Accounted market size in year	US$ 68170 million
Forecasted market size in 2031	US$ 240180 million
CAGR	20.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Immune Checkpoint Inhibitors Immune System Modulators Cancer Vaccines
Segment by Application	Lung Cancer Breast Cancer Colorectal Cancer Melanoma Prostate Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, AstraZeneca, Roche, Bayer, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Immunotherapy Market growing?

Ans: The Cancer Immunotherapy Market witnessing a CAGR of 20.0% during the forecast period 2025-2031.

What is the Cancer Immunotherapy Market size in 2031?

Ans: The Cancer Immunotherapy Market size in 2031 will be US$ 240180 million.

Who are the main players in the Cancer Immunotherapy Market report?

Ans: The main players in the Cancer Immunotherapy Market are Amgen, AstraZeneca, Roche, Bayer, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer

What are the Application segmentation covered in the Cancer Immunotherapy Market report?

Ans: The Applications covered in the Cancer Immunotherapy Market report are Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Others

What are the Type segmentation covered in the Cancer Immunotherapy Market report?

Ans: The Types covered in the Cancer Immunotherapy Market report are Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines

Recommended Reports

Cancer Type Markets

Oncology Therapeutics

Immuno & Targeted Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Immune System Modulators

1.2.4 Cancer Vaccines

1.3 Market by Application

1.3.1 Global Cancer Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Colorectal Cancer

1.3.5 Melanoma

1.3.6 Prostate Cancer

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Immunotherapy Market Perspective (2020-2031)

2.2 Global Cancer Immunotherapy Growth Trends by Region

2.2.1 Global Cancer Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Immunotherapy Historic Market Size by Region (2020-2025)

2.2.3 Cancer Immunotherapy Forecasted Market Size by Region (2026-2031)

2.3 Cancer Immunotherapy Market Dynamics

2.3.1 Cancer Immunotherapy Industry Trends

2.3.2 Cancer Immunotherapy Market Drivers

2.3.3 Cancer Immunotherapy Market Challenges

2.3.4 Cancer Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Immunotherapy Players by Revenue

3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2020-2025)

3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Immunotherapy Revenue

3.4 Global Cancer Immunotherapy Market Concentration Ratio

3.4.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2024

3.5 Global Key Players of Cancer Immunotherapy Head office and Area Served

3.6 Global Key Players of Cancer Immunotherapy, Product and Application

3.7 Global Key Players of Cancer Immunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Immunotherapy Breakdown Data by Type

4.1 Global Cancer Immunotherapy Historic Market Size by Type (2020-2025)

4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2026-2031)

5 Cancer Immunotherapy Breakdown Data by Application

5.1 Global Cancer Immunotherapy Historic Market Size by Application (2020-2025)

5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Immunotherapy Market Size (2020-2031)

6.2 North America Cancer Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Immunotherapy Market Size by Country (2020-2025)

6.4 North America Cancer Immunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Immunotherapy Market Size (2020-2031)

7.2 Europe Cancer Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Immunotherapy Market Size by Country (2020-2025)

7.4 Europe Cancer Immunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Immunotherapy Market Size (2020-2031)

8.2 Asia-Pacific Cancer Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Immunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Immunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Immunotherapy Market Size (2020-2031)

9.2 Latin America Cancer Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Immunotherapy Market Size by Country (2020-2025)

9.4 Latin America Cancer Immunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Immunotherapy Market Size (2020-2031)

10.2 Middle East & Africa Cancer Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Immunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Immunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Cancer Immunotherapy Introduction

11.1.4 Amgen Revenue in Cancer Immunotherapy Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Cancer Immunotherapy Introduction

11.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2020-2025)

11.2.5 AstraZeneca Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Cancer Immunotherapy Introduction

11.3.4 Roche Revenue in Cancer Immunotherapy Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Cancer Immunotherapy Introduction

11.4.4 Bayer Revenue in Cancer Immunotherapy Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Details

11.5.2 Bristol-Myers Squibb Business Overview

11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction

11.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2020-2025)

11.5.5 Bristol-Myers Squibb Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Cancer Immunotherapy Introduction

11.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Cancer Immunotherapy Introduction

11.7.4 Merck Revenue in Cancer Immunotherapy Business (2020-2025)

11.7.5 Merck Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Cancer Immunotherapy Introduction

11.8.4 Novartis Revenue in Cancer Immunotherapy Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Cancer Immunotherapy Introduction

11.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2020-2025)

11.9.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Astrazeneca plc

Roche

Bayer

Bristol–Myers Squibb

Eli Lilly

Merck

Novartis

Pfizer Inc

List of Tables

Table 1. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immune Checkpoint Inhibitors

Table 3. Key Players of Immune System Modulators

Table 4. Key Players of Cancer Vaccines

Table 5. Global Cancer Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cancer Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Cancer Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Cancer Immunotherapy Market Share by Region (2020-2025)

Table 9. Global Cancer Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Cancer Immunotherapy Market Share by Region (2026-2031)

Table 11. Cancer Immunotherapy Market Trends

Table 12. Cancer Immunotherapy Market Drivers

Table 13. Cancer Immunotherapy Market Challenges

Table 14. Cancer Immunotherapy Market Restraints

Table 15. Global Cancer Immunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Cancer Immunotherapy Market Share by Players (2020-2025)

Table 17. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2024)

Table 18. Ranking of Global Top Cancer Immunotherapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Cancer Immunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Cancer Immunotherapy, Headquarters and Area Served

Table 21. Global Key Players of Cancer Immunotherapy, Product and Application

Table 22. Global Key Players of Cancer Immunotherapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cancer Immunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Cancer Immunotherapy Revenue Market Share by Type (2020-2025)

Table 26. Global Cancer Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Cancer Immunotherapy Revenue Market Share by Type (2026-2031)

Table 28. Global Cancer Immunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Cancer Immunotherapy Revenue Market Share by Application (2020-2025)

Table 30. Global Cancer Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Cancer Immunotherapy Revenue Market Share by Application (2026-2031)

Table 32. North America Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Cancer Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Cancer Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Cancer Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Cancer Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Cancer Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Cancer Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Cancer Immunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Cancer Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Cancer Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Cancer Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Cancer Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Amgen Company Details

Table 48. Amgen Business Overview

Table 49. Amgen Cancer Immunotherapy Product

Table 50. Amgen Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 51. Amgen Recent Development

Table 52. AstraZeneca Company Details

Table 53. AstraZeneca Business Overview

Table 54. AstraZeneca Cancer Immunotherapy Product

Table 55. AstraZeneca Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 56. AstraZeneca Recent Development

Table 57. Roche Company Details

Table 58. Roche Business Overview

Table 59. Roche Cancer Immunotherapy Product

Table 60. Roche Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 61. Roche Recent Development

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Cancer Immunotherapy Product

Table 65. Bayer Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 66. Bayer Recent Development

Table 67. Bristol-Myers Squibb Company Details

Table 68. Bristol-Myers Squibb Business Overview

Table 69. Bristol-Myers Squibb Cancer Immunotherapy Product

Table 70. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 71. Bristol-Myers Squibb Recent Development

Table 72. Eli Lilly Company Details

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Cancer Immunotherapy Product

Table 75. Eli Lilly Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 76. Eli Lilly Recent Development

Table 77. Merck Company Details

Table 78. Merck Business Overview

Table 79. Merck Cancer Immunotherapy Product

Table 80. Merck Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 81. Merck Recent Development

Table 82. Novartis Company Details

Table 83. Novartis Business Overview

Table 84. Novartis Cancer Immunotherapy Product

Table 85. Novartis Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 86. Novartis Recent Development

Table 87. Pfizer Company Details

Table 88. Pfizer Business Overview

Table 89. Pfizer Cancer Immunotherapy Product

Table 90. Pfizer Revenue in Cancer Immunotherapy Business (2020-2025) & (US$ Million)

Table 91. Pfizer Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Cancer Immunotherapy Picture

Figure 2. Global Cancer Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Immunotherapy Market Share by Type: 2024 VS 2031

Figure 4. Immune Checkpoint Inhibitors Features

Figure 5. Immune System Modulators Features

Figure 6. Cancer Vaccines Features

Figure 7. Global Cancer Immunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Cancer Immunotherapy Market Share by Application: 2024 VS 2031

Figure 9. Lung Cancer Case Studies

Figure 10. Breast Cancer Case Studies

Figure 11. Colorectal Cancer Case Studies

Figure 12. Melanoma Case Studies

Figure 13. Prostate Cancer Case Studies

Figure 14. Others Case Studies

Figure 15. Cancer Immunotherapy Report Years Considered

Figure 16. Global Cancer Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Cancer Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Cancer Immunotherapy Market Share by Region: 2024 VS 2031

Figure 19. Global Cancer Immunotherapy Market Share by Players in 2024

Figure 20. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2024

Figure 22. North America Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Cancer Immunotherapy Market Share by Country (2020-2031)

Figure 24. United States Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Cancer Immunotherapy Market Share by Country (2020-2031)

Figure 28. Germany Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Cancer Immunotherapy Market Share by Region (2020-2031)

Figure 36. China Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Cancer Immunotherapy Market Share by Country (2020-2031)

Figure 44. Mexico Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Cancer Immunotherapy Market Share by Country (2020-2031)

Figure 48. Turkey Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Cancer Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 53. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 54. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 56. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 57. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 58. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 59. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Cancer Biologics Market Research Report 2024

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Immunotherapy Drugs Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Immunocell Therapy Market Insights Forecast to 2030

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Biopharmaceuticals Market Insights Forecast to 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno Cell Therapy Market Research Report 2024

Global Adoptive Cell Therapy Market Insights Forecast to 2030

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumor Immunotherapy Market

Global Immuno Oncology Treatment Market Insights Forecast to 2030

Global Natural Killer Cell Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions